“…Alternatively, it may be due to interference of the nucleation process as inferred in the case of nimodipine:nifedipine co-amorphous blends wherein the T g of the mixture was lower than expected but the system was nevertheless more resistant to crystallization (Knapik-Kowalczuk et al, 2018). However, in terms of dissolution assessment, in many cases, comparisons are made between the co-amorphous system and the corresponding crystalline forms (Dengale et al, 2014, Shayanfar and Jouyban, 2013, Tantishaiyakul et al, 2009). Occasions wherein the dissolution performance is improved relative to that of the pure amorphous drug are usually seen in cases where the amorphous co-former is acidic and the drug is a base, hence salt formation occurs, or the acidic component increases the solubility of the drug by modifying the micro-environmental pH of the solute–solvent interface (Fung et al, 2018).…”